CED Life Science Conference 2017 - Innovation Room
Sub-sector: Biotech and Pharmaceutical
Year Founded: 2004
Biomarck is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides in order to develop and license products targeted at difficult to treat diseases with unmet needs. We are located in Research Triangle Park, N.C. Our company has a worldwide patented drug platform of over 100 peptides that inhibit the phosphorylation of the MARCKS protein, a well published primary mediator of an inflammatory cytokine release involved in respiratory disease and cancer progression.
Dr. Brian Dickson, Chief Executive Officer
Dr. Indu Parikh, Chief Scientific Officer
KEY MILESTONES TO DATE
- IND's submitted. Phase 1 completed
NC State Office of Technology Transfer (OTT)
Learn more about the CED Life Science Conference.